Andrea Murray

Title: Andrea Murray and a Liver Cancer Antibody Assay

Introduction

Andrea Murray is an inventor associated with Nottingham, Great Britain. Her patent work concerns antibody-based methods for detecting liver cancer and supporting related diagnosis and treatment decisions. The supplied information lists 1 patent and identifies Freenome Holdings, Inc. as her company.

Latest Patents

Murray’s listed patent, “Antibody Assay for the Detection and Treatment of Liver Cancer,” describes testing a bodily-fluid sample for autoantibodies that are specific to tumour marker proteins. The markers named in the invention are MMP9, AIF1, EpCAM, and CDKN1B. The method contacts the sample with a selected tumour marker antigen and checks whether antigen–autoantibody complexes are present; their presence may indicate liver cancer.

The invention also describes related methods for diagnosing and treating liver cancer, predicting a patient’s response to anti-cancer treatment, detecting antibodies in bodily-fluid samples, and providing kits for carrying out the methods.

Career Highlights

The available information connects Murray’s patent activity with Freenome Holdings, Inc. Her listed invention focuses on using immune responses to tumour markers as a potential tool in liver cancer assessment.

Collaborations

The supplied data names Jared Allen and Isabel Macdonald as Murray’s coworkers. It does not specify their roles in the patent or describe particular collaborative contributions.

Conclusion

Andrea Murray’s listed patent presents an antibody-based approach to liver cancer detection, with related applications in diagnosis, treatment planning, and response prediction.